Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GenVec Inc announces collaboration with Novartis


Thursday, 13 Feb 2014 06:00am EST 

GenVec Inc:Says it has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders.Says in Jan. Novartis filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for the clinical development of CGF166, the lead product candidate under the collaboration.Says IND was deemed effective on Feb. 7 and this triggered a $2 million milestone payment to GenVec under the terms of the collaboration. 

Company Quote

2.12
0.06 +2.91%
26 Dec 2014